Other dysregulated transcriptomic networks underlying AML LSC-mediated therapy resistance and survival include the canonical nuclear factor κB (NFκB) pathway [131,132], depletion of the transcription factor GLI3 in the hedgehog signaling pathway [133,134,135], and c-Myc dysregulation [136]. Here, NFKB1 is linked to acute myeloid leukemia.